These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
207 related articles for article (PubMed ID: 24981643)
1. Associations of psychotherapy dose and SSRI or SNRI refills with mental health outcomes among veterans with PTSD. Shin HJ; Greenbaum MA; Jain S; Rosen CS Psychiatr Serv; 2014 Oct; 65(10):1244-8. PubMed ID: 24981643 [TBL] [Abstract][Full Text] [Related]
2. Pharmacotherapy for posttraumatic stress disorder at a Veterans Affairs facility. Kobayashi TM; Patel M; Lotito M Am J Health Syst Pharm; 2015 Jun; 72(11 Suppl 1):S11-5. PubMed ID: 25991587 [TBL] [Abstract][Full Text] [Related]
3. Trends in Medication Prescribing in Patients With PTSD From 2009 to 2018: A National Veterans Administration Study. Holder N; Woods A; Neylan TC; Maguen S; Seal KH; Bernardy N; Wiechers I; Ryder A; Urbieta AM; Cohen BE J Clin Psychiatry; 2021 May; 82(3):. PubMed ID: 34004087 [TBL] [Abstract][Full Text] [Related]
4. Comparative safety of benzodiazepines and opioids among veterans affairs patients with posttraumatic stress disorder. Hawkins EJ; Malte CA; Grossbard J; Saxon AJ; Imel ZE; Kivlahan DR J Addict Med; 2013; 7(5):354-62. PubMed ID: 24091764 [TBL] [Abstract][Full Text] [Related]
5. PTSD, Psychotropic Medication Use, and the Risk of Dementia Among US Veterans: A Retrospective Cohort Study. Mawanda F; Wallace RB; McCoy K; Abrams TE J Am Geriatr Soc; 2017 May; 65(5):1043-1050. PubMed ID: 28176297 [TBL] [Abstract][Full Text] [Related]
6. Posttraumatic Stress Disorder, Antidepressant Use, and Hemorrhagic Stroke in Young Men and Women: A 13-Year Cohort Study. Gaffey AE; Rosman L; Burg MM; Haskell SG; Brandt CA; Skanderson M; Dziura J; Sico JJ Stroke; 2021 Jan; 52(1):121-129. PubMed ID: 33297868 [TBL] [Abstract][Full Text] [Related]
7. Comparison of adjunctive use of aripiprazole with bupropion or selective serotonin reuptake inhibitors/serotonin-norepinephrine reuptake inhibitors: analysis of patients beginning adjunctive treatment in a 52-week, open-label study. Clayton AH; Baker RA; Sheehan JJ; Cain ZJ; Forbes RA; Marler SV; Marcus R; Berman RM; Thase ME BMC Res Notes; 2014 Jul; 7():459. PubMed ID: 25037144 [TBL] [Abstract][Full Text] [Related]
8. Randomized Controlled Trial of Riluzole Augmentation for Posttraumatic Stress Disorder: Efficacy of a Glutamatergic Modulator for Antidepressant-Resistant Symptoms. Spangler PT; West JC; Dempsey CL; Possemato K; Bartolanzo D; Aliaga P; Zarate C; Vythilingam M; Benedek DM J Clin Psychiatry; 2020 Oct; 81(6):. PubMed ID: 33113596 [TBL] [Abstract][Full Text] [Related]
9. Gender differences in prescribing among veterans diagnosed with posttraumatic stress disorder. Bernardy NC; Lund BC; Alexander B; Jenkyn AB; Schnurr PP; Friedman MJ J Gen Intern Med; 2013 Jul; 28 Suppl 2(Suppl 2):S542-8. PubMed ID: 23807063 [TBL] [Abstract][Full Text] [Related]
11. Mental Health Treatment for Older Veterans Newly Diagnosed with PTSD: A National Investigation. Smith NB; Cook JM; Pietrzak R; Hoff R; Harpaz-Rotem I Am J Geriatr Psychiatry; 2016 Mar; 24(3):201-12. PubMed ID: 25772341 [TBL] [Abstract][Full Text] [Related]
12. Effect of Selective Serotonin Reuptake Inhibitors on Healthcare Utilization in Patients with Post-Traumatic Stress Disorder and Alcohol Use Disorder. Naglich AC; Bozeman S; Brown ES; Adinoff B Alcohol Alcohol; 2019 Jul; 54(4):428-434. PubMed ID: 31185085 [TBL] [Abstract][Full Text] [Related]
13. Patient and Clinical Factors Associated With Response to Medications for Posttraumatic Stress Disorder. Shiner BR; Gui J; Rozema L; Cornelius SL; Dufort V; Schnurr PP; Watts BV J Clin Psychiatry; 2021 Oct; 82(6):. PubMed ID: 34610227 [No Abstract] [Full Text] [Related]
14. Do veterans with posttraumatic stress disorder receive first-line pharmacotherapy? Results from the longitudinal veterans health survey. Jain S; Greenbaum MA; Rosen CS Prim Care Companion CNS Disord; 2012; 14(2):. PubMed ID: 22943028 [TBL] [Abstract][Full Text] [Related]
15. 3,4-methylenedioxymethamphetamine (MDMA)-assisted psychotherapy for post-traumatic stress disorder in military veterans, firefighters, and police officers: a randomised, double-blind, dose-response, phase 2 clinical trial. Mithoefer MC; Mithoefer AT; Feduccia AA; Jerome L; Wagner M; Wymer J; Holland J; Hamilton S; Yazar-Klosinski B; Emerson A; Doblin R Lancet Psychiatry; 2018 Jun; 5(6):486-497. PubMed ID: 29728331 [TBL] [Abstract][Full Text] [Related]
16. Comparative assessment of adherence measures and resource use in SSRI/SNRI-treated patients with depression using second-generation antipsychotics or L-methylfolate as adjunctive therapy. Wade RL; Kindermann SL; Hou Q; Thase ME J Manag Care Pharm; 2014 Jan; 20(1):76-85. PubMed ID: 24372461 [TBL] [Abstract][Full Text] [Related]
17. Open-label trial of escitalopram in the treatment of posttraumatic stress disorder. Robert S; Hamner MB; Ulmer HG; Lorberbaum JP; Durkalski VL J Clin Psychiatry; 2006 Oct; 67(10):1522-6. PubMed ID: 17107242 [TBL] [Abstract][Full Text] [Related]
18. An open trial of paroxetine in patients with noncombat-related, chronic posttraumatic stress disorder. Marshall RD; Schneier FR; Fallon BA; Knight CB; Abbate LA; Goetz D; Campeas R; Liebowitz MR J Clin Psychopharmacol; 1998 Feb; 18(1):10-8. PubMed ID: 9472837 [TBL] [Abstract][Full Text] [Related]